<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="Activity\PMC7756214\results\search\disease\results.xml">
  <result pre="the notification from the Paulâ€�Ehrlichâ€�Institut of cases of possible immuneâ€�related" exact="encephalitis" post="in association with daclizumab, a medicine used to treat"/>
  <result pre="medicine used to treat adult patients with relapsing forms of" exact="multiple sclerosis." post="An IRN meeting was promptly convened and after consideration"/>
  <result pre="intention to terminate several ongoing clinical trials with idelalisib, a" exact="cancer" post="medicine used to treat adult patients with chronic lymphocytic"/>
  <result pre="idelalisib, a cancer medicine used to treat adult patients with" exact="chronic lymphocytic leukemia" post="(CLL) or follicular lymphoma, due to increased risk of"/>
  <result pre="cancer medicine used to treat adult patients with chronic lymphocytic" exact="leukemia" post="(CLL) or follicular lymphoma, due to increased risk of"/>
  <result pre="to treat adult patients with chronic lymphocytic leukemia (CLL) or" exact="follicular lymphoma," post="due to increased risk of serious respiratory infections and"/>
  <result pre="monitoring of these and adequate prophylaxis specifically for Pneumocystis jirovecii" exact="pneumonia" post="(during treatment and up to 6 months after interruption)"/>
  <result pre="Medicines Agency . EMA recommends immediate suspension and recall of" exact="multiple sclerosis" post="medicine Zinbryta [Web page]. https://www.ema.europa.eu/en/news/ema-recommends-immediate-suspension-recall-multiple-sclerosis-medicine-zinbryta. Accessed November 13, 2019."/>
  <result pre="for the treatment of chronic lymphocytic leukaemia (CLL) and relapsed" exact="follicular lymphoma" post="(FL) following new clinical trial results. https://assets.publishing.service.gov.uk/media/5707baba40f0b60385000056/Zydelig__idelalisib__â€�_DHPC_sent_23_03_2016.pdf. Accessed November"/>
  <result pre="the treatment of chronic lymphocytic leukaemia (CLL) and relapsed follicular" exact="lymphoma" post="(FL) following new clinical trial results. https://assets.publishing.service.gov.uk/media/5707baba40f0b60385000056/Zydelig__idelalisib__â€�_DHPC_sent_23_03_2016.pdf. Accessed November"/>
 </snippets>
</snippetsTree>
